Acute lymphoblastic leukemia other diagnostic studies: Difference between revisions
Shyam Patel (talk | contribs) (→Biopsy) |
Kamal Akbar (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
==Cytogenetics== | ==Cytogenetics== | ||
[[Cytogenetics]] | *In [[Cytogenetics]] the following establishes whether the "blast" cells began from the [[B lymphocyte]]s or [[T lymphocyte]]s | ||
**[[Philadelphia chromosome]]) | |||
**[[immunophenotyping]] | |||
*DNA testing can establish how aggressive the disease is; different mutations have been associated with shorter or longer survival. | |||
==Biopsy== | ==Biopsy== | ||
A [[biopsy]] is the only sure way to know whether leukemia cells are in the bone marrow | *A [[biopsy]] is the only sure way to know whether leukemia cells are in the bone marrow | ||
*Before the sample is taken, local anesthesia is used to numb the area. This helps reduce the pain. | |||
*Bone marrow from your hipbone or another large bone is taken as biopsy.<ref>[http://www.accessmedicine.com/content.aspx?aID=65842 Harrison's Principles of Internal Medicine, 16th EditioN,] Chapter 97. Malignancies of Lymphoid Cells. Clinical Features, Treatment, and Prognosis of Specific Lymphoid Malignancies.</ref> | |||
*On biopsy the following is seen: | |||
**High number of lymphoblast | |||
A bone marrow biopsy and aspirate are routinely performed even in T-cell acute lymphoblastic leukemia to determine the extent of marrow involvement. Malignant cells should be sent for conventional cytogenetic studies, as detection of the Ph1 t(9;22), myc gene rearrangements (in Burkitt leukemia), and ''MLL'' gene rearrangements add important prognostic information<ref name=ALL>{{cite web | title = National Cancer Institute| url =http://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq#link/_44_toc }}</ref> | A bone marrow biopsy and aspirate are routinely performed even in T-cell acute lymphoblastic leukemia to determine the extent of marrow involvement. Malignant cells should be sent for conventional cytogenetic studies, as detection of the Ph1 t(9;22), myc gene rearrangements (in Burkitt leukemia), and ''MLL'' gene rearrangements add important prognostic information<ref name=ALL>{{cite web | title = National Cancer Institute| url =http://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq#link/_44_toc }}</ref> | ||
Revision as of 20:56, 1 February 2019
|
Acute lymphoblastic leukemia Microchapters |
|
Differentiating Acute lymphoblastic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute lymphoblastic leukemia other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Acute lymphoblastic leukemia other diagnostic studies |
|
FDA on Acute lymphoblastic leukemia other diagnostic studies |
|
CDC on Acute lymphoblastic leukemia other diagnostic studies |
|
Acute lymphoblastic leukemia other diagnostic studies in the news |
|
Blogs on Acute lymphoblastic leukemia other diagnostic studies |
|
Directions to Hospitals Treating Acute lymphoblastic leukemia |
|
Risk calculators and risk factors for Acute lymphoblastic leukemia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3]
Overview
Other diagnostic studies for acute lymphoblastic leukemia include cytogenetics, bone marrow biopsy, flow cytometry, RT-PCR and FISH.
Cytogenetics
- In Cytogenetics the following establishes whether the "blast" cells began from the B lymphocytes or T lymphocytes
- DNA testing can establish how aggressive the disease is; different mutations have been associated with shorter or longer survival.
Biopsy
- A biopsy is the only sure way to know whether leukemia cells are in the bone marrow
- Before the sample is taken, local anesthesia is used to numb the area. This helps reduce the pain.
- Bone marrow from your hipbone or another large bone is taken as biopsy.[1]
- On biopsy the following is seen:
- High number of lymphoblast
A bone marrow biopsy and aspirate are routinely performed even in T-cell acute lymphoblastic leukemia to determine the extent of marrow involvement. Malignant cells should be sent for conventional cytogenetic studies, as detection of the Ph1 t(9;22), myc gene rearrangements (in Burkitt leukemia), and MLL gene rearrangements add important prognostic information[2]
Flow cytometry
Flow cytometry should be performed to characterize expression of lineage-defining antigens and allow determination of the specific acute lymphoblastic leukemia subtype.[2]
RT-PCR and FISH
- In addition, for B-cell disease the malignant cells should be analyzed using RT-PCR and FISH for evidence of the bcr-abl fusion gene. This last point is of utmost importance, as timely diagnosis of Ph1 acute lymphoblastic leukemia will significantly change the therapeutic approach.[2]
References
- ↑ Harrison's Principles of Internal Medicine, 16th EditioN, Chapter 97. Malignancies of Lymphoid Cells. Clinical Features, Treatment, and Prognosis of Specific Lymphoid Malignancies.
- ↑ 2.0 2.1 2.2 "National Cancer Institute".